SCHEMBL13487262

SCHEMBL13487262

CC1(C)c2ccccc2-c2c(-c3c4ccccc4c(-c4ccc5oc6ccccc6c5c4)c4ccc(-c5ccc6ccccc6c5)cc34)cccc21

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP3 P42574 1/20 0.34
SENP7 Q9BQF6 1/20 0.34
SENP6 Q9GZR1 1/20 0.34
HSP90AA1 P07900 1/20 0.34
HSP90AB1 P08238 1/20 0.34
HCRTR1 O43613 1/20 0.32
LPL P06858 1/20 0.32
LIPG Q9Y5X9 1/20 0.32
IDO1 P14902 1/20 0.31
PTGER3 P43115 2/20 0.31
KDM4E B2RXH2 2/20 0.31
MEN1 O00255 2/20 0.31
ALDH1A1 P00352 2/20 0.31
MAPT P10636 2/20 0.31
KMT2A Q03164 2/20 0.31
NPC1 O15118 1/20 0.31
HPGD P15428 1/20 0.31
RAB9A P51151 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
PGR P06401 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13487259 0.91 CASP3 (0.33) CASP3SENP7SENP6HCRTR1LPL
SCHEMBL13487159 0.91 HSP90AA1 (0.34) CASP3SENP7SENP6HSP90AA1HSP90AB1
SCHEMBL13487099 0.91 PLA2G2A (0.37) CASP3SENP7SENP6HSP90AA1HSP90AB1
SCHEMBL24130419 0.90 HSP90AA1 (0.39) CASP3SENP7SENP6HSP90AA1HSP90AB1
SCHEMBL13487260 0.90 ALOX5 (0.40) CASP3SENP7SENP6HCRTR1LPL
SCHEMBL13488036 0.90 CASP3 (0.35) CASP3SENP7SENP6HSP90AA1HSP90AB1
SCHEMBL13487344 0.90 HSP90AA1 (0.35) CASP3SENP7SENP6HSP90AA1HSP90AB1
SCHEMBL26404576 0.88 HSP90AA1 (0.32) CASP3SENP7SENP6HSP90AA1HSP90AB1
SCHEMBL13487035 0.88 MAOB (0.35) HSP90AA1HSP90AB1IDO1KDM4EMEN1
SCHEMBL17851829 0.87 HSP90AA1 (0.36) CASP3SENP7SENP6HSP90AA1HSP90AB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-25 US disclosed
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-25 US disclosed
EP-2108689-A2 Novel organic electroluminescent compounds and organic electroluminescent device using the same Gracel Display Inc. (KR) 2009-10-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, OCIAD2, ORMDL3 CASP3 3093/4885SENP7 3726/4885SENP6 3542/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.